LATEST MANUSCRIPTS IN Journal of Molecular and Cellular Cardiology Plus
Yuli W Heinson, Julie L Han, Emilia Entcheva. OptoDyCE-plate as an affordable high throughput imager for all optical cardiac electrophysiology.Journal of molecular and cellular cardiology plus. 2023, 6:
Jules C Hancox, Caroline S Copeland, Stephen C Harmer, Graeme Henderson. New synthetic cannabinoids and the potential for cardiac arrhythmia risk.Journal of molecular and cellular cardiology plus. 2023, 6: 100049
Irina Zalivina, Temo Barwari, Xiaoke Yin, Sarah R Langley, Javier Barallobre-Barreiro, Hiroko Wakimoto, Anna Zampetaki, Manuel Mayr, Metin Avkiran, Seda Eminaga. Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling.Journal of molecular and cellular cardiology plus. 2023, 6: 100056
Kazi T Haq, Anysja Roberts, Fiona Berk, Samuel Allen, Luther M Swift, Nikki Gillum Posnack. KairoSight-3.0: A validated optical mapping software to characterize cardiac electrophysiology, excitation-contraction coupling, and alternans.Journal of molecular and cellular cardiology plus. 2023, 5:
Cody A Rutledge, Claudia Lagranha, Takuto Chiba, Kevin Redding, Donna B Stolz, Eric Goetzman, Sunder Sims-Lucas, Brett A Kaufman. Metformin preconditioning protects against myocardial stunning and preserves protein translation in a mouse model of cardiac arrest.Journal of molecular and cellular cardiology plus. 2023, 4:
Timothy A McCaffrey, Ian Toma, Zhaoqing Yang, Richard Katz, Jonathan Reiner, Ramesh Mazhari, Palak Shah, Zachary Falk, Richard Wargowsky, Jennifer Goldman, Dan Jones, Dmitry Shtokalo, Denis Antonets, Tisha Jepson, Anastasia Fetisova, Kevin Jaatinen, Natalia Ree, Maxim Ri. RNAseq profiling of blood from patients with coronary artery disease: Signature of a T cell imbalance.Journal of molecular and cellular cardiology plus. 2023, 4:
Hamid Suhail, Hongmei Peng, Jiang Xu, Hani N Sabbah, Khalid Matrougui, Tang-Dong Liao, Pablo A Ortiz, Kenneth E Bernstein, Nour-Eddine Rhaleb. Knockout of ACE-N facilitates improved cardiac function after myocardial infarction.Journal of molecular and cellular cardiology plus. 2023, 3:
Cora C Hart, Young Il Lee, David W Hammers, H Lee Sweeney. Evaluation of the DBA/2J mouse as a potential background strain for genetic models of cardiomyopathy.Journal of molecular and cellular cardiology plus. 2022, 1:
Vasco Sequeira, Lili Wang, Paul J M Wijnker, Kyungsoo Kim, Jose R Pinto, Cris Dos Remedios, Charles Redwood, Bjorn C Knollmann, Jolanda van der Velden. Low expression of the K280N mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy.Journal of molecular and cellular cardiology plus. 2022, 1: 100007
Amela Jusic, Konstantinos Stellos, Lino Ferreira, Andrew H Baker, Yvan Devaux. (Epi)transcriptomics in cardiovascular and neurological complications of COVID-19.Journal of molecular and cellular cardiology plus. 2022, 1: 100013
Christian Schulte, Bhawana Singh, Konstantinos Theofilatos, Nils A Sörensen, Jonas Lehmacher, Tau Hartikainen, Paul M Haller, Dirk Westermann, Tanja Zeller, Stefan Blankenberg, Johannes T Neumann, Manuel Mayr. Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes.Journal of molecular and cellular cardiology plus. 2022, 1: None